Phase 1 Norwalk Vaccine Study

NCT00806962 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Norovirus

Interventions

DRUG: Adjuvant/Excipients
DEVICE: placebo
BIOLOGICAL: Norwalk VLP Vaccine
BIOLOGICAL: Norwalk VLP Vaccine

Sponsor

LigoCyte Pharmaceuticals, Inc.